We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

600036:SSEChina Merchants Bank Co., Ltd. Class A Analysis

Data as of 2026-03-11 - not real-time

CN¥39.50

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

China Merchants Bank (600036) trades at a trailing PE of 6.95, far below the industry average of 17.29, and its price‑to‑book ratio sits under 1 (0.91), suggesting a sizeable valuation cushion. The bank delivers robust profitability with an operating margin of 39% and a profit margin of 44%, while revenue has surged by more than 50% year‑over‑year, underscoring strong growth momentum. Dividend attractiveness is a standout feature, offering a 7.68% yield on a modest 35% payout ratio, which appears sustainable given the solid cash base. Technically, the stock is hovering near its short‑term support at 38.01 CNY and below its 50‑day SMA (39.74), with a bearish trend label, yet the MACD histogram is positive and the RSI sits at a neutral 54, indicating potential for a short‑term bounce.
Given the low computed beta (0.08) and stable volume, the equity exhibits low market‑related volatility, though the 30‑day price volatility of 15.6% reflects some price swing. The combination of deep valuation discounts, high dividend yield, and strong earnings growth points to a compelling medium‑ to long‑term case, while the near‑term technical picture suggests a cautious “hold” stance until price confirms a breakout above resistance around 39.95 CNY.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD histogram despite overall bearish trend
  • High dividend yield offering immediate income
  • Price near short‑term support with limited upside to resistance

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant revenue growth (>50%) and strong profit margins
  • Valuation far below peers (PE 6.95 vs 17.3 industry average)
  • Sustainable high dividend yield supporting total return

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Low beta indicating defensive characteristics
  • Robust cash position and solid ROE (~12%)
  • Continued undervaluation with attractive dividend and growth prospects

Key Metrics & Analysis

Financial Health

Revenue Growth54.60%
Profit Margin44.49%
P/E Ratio7.0
ROE11.97%
P/B Ratio0.9
Industry P/E17.3

Technical Analysis

TrendBearish
RSI54.0
SupportCN¥38.01
ResistanceCN¥39.95
MA 20CN¥39.09
MA 50CN¥39.74
MA 200CN¥42.59
MACDBullish
VolumeStable
Fear & Greed Index76.8

Valuation

GradeUndervalued
TypeGrowth
Dividend Yield7.68%

Risk Assessment

Beta0.08
Volatility15.63%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.